[ Price : $8.95]
Akorn pays $7.9 million to resolve allegations that it caused Medicare to submit false claims by delaying an Rx to OTC switch for ...[ Price : $8.95]
A MasterControl white paper lists the processes involved in the most common FDA medical device observations and Warning Letters.[ Price : $8.95]
FDA grants in part and declines in part a Catalyst Pharmaceuticals petition on using amifampridine to treat congenital myasthenic ...[ Price : $8.95]
Novartis asks FDA not to approve ANDAs seeking to produce a generic form of its Entresto under specific conditions.[ Price : $8.95]
FDA denies a petition asking it to standardize hearing aid features in new over-the-counter hearing aids and rate them.[ Price : $8.95]
FDA joins the National Institutes of Health in launching a Critical Path for Rare Neurodegenerative Diseases public-private partne...[ Price : $8.95]
Federal Register notice: FDA determines for patent extension purposes the regulatory review period for Eli Lillys migraine drug Re...[ Price : $8.95]
CDER director Patrizia Cavazzoni removes Bob Temples deputy Center director title and renames him senior advisor for clinical scie...